
zzso zzso clinical zzso zzso zzso and outcome of zzso status zzso zzso in cancer patients on whom an zzso was zzso 

zzso review of zzso zzso reports on zzso patients in whom any type of zzso was performed at Memorial zzso Cancer Center zzso 2006 to March zzso Using the zzso Research Foundation criteria, patients were classified as zzso or probable zzso Medical records were reviewed for diagnosis, causes of zzso response to treatment, and zzso zzso was determined for patients with zzso 

Twenty-six episodes of zzso were identified in 25 patients zzso zzso Eleven patients had primary brain zzso 12 patients systemic cancer, and two had zzso At diagnostic zzso 18 were awake, 3 were zzso and 5 patients were zzso zzso revealed a seizure in zzso of the patients, periodic zzso zzso zzso in zzso and periodic zzso zzso in zzso zzso revealed new zzso pathology in zzso of the zzso zzso percent of the patients achieved zzso zzso required zzso zzso drugs, and zzso required zzso Three patients died from zzso 

In our zzso awake zzso was more common than comatose zzso Treatment was successful in patients with zzso central nervous system zzso zzso evaluation should be considered in patients with cancer because zzso is zzso despite a high prevalence of structural brain zzso zzso status zzso control did not always require zzso and burst suppression, but frequently required three or more zzso zzso 

